Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Blake

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|July 20, 2023
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccinesNatalie E Stevens, Feargal J Ryan, Nicole L Messina, et al.
Journal of the American Heart Association|November 12, 2025
Development of a Novel Murine Model of In-Stent NeoatherosclerosisJiandi Liu, Demeke Geremew, Lauren Y Sandeman, et al.
Cancer Discovery|January 21, 2016
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer ImmunotherapyStephen J Blake, Kimberley Stannard, Jing Liu, et al.
Cell Reports. Medicine|January 14, 2022
The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiotaStephen J Blake, Jane James, Feargal J Ryan, et al.
Cancer Immunology Research|March 22, 2019
CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor FunctionDeepak Mittal, Ailin Lepletier, Jason Madore, et al.
Nature Immunology|August 1, 2017
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellsYulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Cell Reports|August 25, 2021
The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later lifeMiriam A Lynn, Georgina Eden, Feargal J Ryan, et al.
Nature Immunology|March 22, 2024
Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellYulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Nature|April 2, 2025
Bifidobacteria support optimal infant vaccine responsesFeargal J Ryan, Michelle Clarke, Miriam A Lynn, et al.
JCI Insight|October 5, 2016
Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host diseaseLaëtitia Le Texier, Katie E Lineburg, Benjamin Cao, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|July 20, 2023
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccinesNatalie E Stevens, Feargal J Ryan, Nicole L Messina, et al.
Journal of the American Heart Association|November 12, 2025
Development of a Novel Murine Model of In-Stent NeoatherosclerosisJiandi Liu, Demeke Geremew, Lauren Y Sandeman, et al.
Cancer Discovery|January 21, 2016
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer ImmunotherapyStephen J Blake, Kimberley Stannard, Jing Liu, et al.
Cell Reports. Medicine|January 14, 2022
The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiotaStephen J Blake, Jane James, Feargal J Ryan, et al.
Cancer Immunology Research|March 22, 2019
CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor FunctionDeepak Mittal, Ailin Lepletier, Jason Madore, et al.
Nature Immunology|August 1, 2017
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellsYulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Cell Reports|August 25, 2021
The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later lifeMiriam A Lynn, Georgina Eden, Feargal J Ryan, et al.
Nature Immunology|March 22, 2024
Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellYulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Nature|April 2, 2025
Bifidobacteria support optimal infant vaccine responsesFeargal J Ryan, Michelle Clarke, Miriam A Lynn, et al.
JCI Insight|October 5, 2016
Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host diseaseLaëtitia Le Texier, Katie E Lineburg, Benjamin Cao, et al.
Pageof 4